We use cookies to improve your experience on our site and to show you personalised advertising. To find out more, read our privacy policy and cookie policy

NHMRC Funding

National Health and Medical Research Council (NHMRC)

NHMRC funding supports research across the full spectrum of health and medical research, from basic science through to clinical, public health and health services research.

All NHMRC grant submissions must go via UOW’s Research Services Office (RSO).

Sapphire is the new web-based system used for submission replacing RGMS. If you have an existing RGMS account you can activate your own account. If you do not have an RGMS Profile you will need to register for an account. See the Sapphire landing page for information on account access.

NHMRC funding opportunities can be viewed by date on the NHMRC Funding Calendar, or grants and all related documents can be viewed via GrantConnect, the Australian Government’s central grants information portal which provides access to opportunities and documentation on Commonwealth grant schemes.

Grants program 

The NHMRC introduced a new grants program, with the first round of funding commencing from 2020. Further information can be found on the NHMRC Website, and RSO presentations on the following new schemes can be found on the RSO intranet:

- Investigator grants
- Ideas grants
- Synergy Grants

Grants held under NHMRC's previous and new grant schemes may impact on eligibility under the new grant program. Any questions should be directed to the RSO via rao-uow@uow.edu.au

Strategic and leveraging grants stream

This stream includes schemes that address strategic and national priorities and support leveraged funding. This includes: targeted calls for research, clinical trials and cohort studies, international collaborative grants, and other strategic initiatives. Strategic and leveraging grants do not affect eligibility for grants under the new grants program.

NHMRC funding opportunities

The new grants program

The new grants program is comprised of the following funding streams:

  • Investigator Grants- provides researchers at all career stages (early career, mid-career and established researchers
  • Ideas Grants- provides funding for up to 5 years for innovative research, in any area of health and medical research
  • Synergy Grants- supports outstanding multidisciplinary teams (4-10 CIs) to work together to answer major research questions 

Strategic and leveraging grants stream

This stream includes schemes that address strategic and national priorities and support leveraged funding. This includes: targeted calls for research, international collaborative grants, other strategic initiatives. This strategic and leveraging grants stream includes the following funding opportunities:

  • Clinical Trials and Cohort Studies Grants- support high-quality clinical trials and cohort studies that address important gaps in knowledge
  • Centres of Research Excellence (CRE)- provides support for teams of researchers to pursue collaborations in clinical, population health and health services research
  • Development Grants- provides support for researchers to undertake health and medical research at the proof-of-concept stage, driving towards a commercial outcome
  • Partnerships for Better Health- supports more effective connections between policy decision makers and researchers
  • Postgraduate Scholarships- aims to support graduates early in their career to conduct research that is internationally competitive

 

Investigator Grants provide researchers at all career stages (early career, mid-career and established researchers), with salary funding (if eligible) and a research support package. Investigator Grants are offered over 5 years and under 2 categories: "Emerging Leadership Fellows" (≤10 years post-PhD) and "Leadership Fellows".

Ideas Grants will provide funding for up to 5 years for creative research, in any area of health and medical research, from discovery to implementation. Investigators at all career stages, including early and mid-career are eligible to apply

Synergy Grants support outstanding multidisciplinary teams (4-10 CIs) to work together to answer major research questions that cannot be answered by a single CI. These grants will provide fixed funding of $5 million over 5 years

Clinical Trials and Cohort Studies Grants aim to support high-quality clinical trials and cohort studies that address important gaps in knowledge, leading to relevant and implementable findings for the benefit of human health

The CRE scheme provides support for teams of researchers to pursue collaborations in clinical, population health and health services research*. The research should aim to improve translation of research outcomes into policy and/or practice. Funding up to $2.5 million over 5 years is available

* In the 2020 submission round, an additional application stream for Dementia Research is available, with funding of up to $3 million over 5 years.

The Development Grants scheme provides support for researchers to undertake health and medical research at the proof-of-concept stage, and which drives towards a commercial outcome via a commercial business plan

Partnerships for Better Health (Partnership Centres and Projects) aim to support more effective connections between policy decision makers and researchers. Partnership Project applications are accepted on a continuous basis which allows researchers and partners to develop timely collaborations

This scheme provides 3 years of funding for a research based postgraduate degree. It aims to support graduates early in their career to conduct research that is internationally competitive.

Past grant recipients

YearNameTitleAgency ref. no.Total
2017 Thomas Astell-Burt Do urban green spaces help to reduce incidence of Alzheimer's and associated risk factors? Multilevel longitudinal study of 267,153 adults with 15 years of follow-up APP1140317 $719,840.80
2017 Lezanne Ooi Neuronal membranes and connections in dementia: targets for intervention APP1135720 $720,144.00
YearNameTitleAgency ref. no.Total
2018 Xiaoqi Feng Classifying local environment attributes for healthier, more equitable child development APP1148792 $431,000
2015 Justin Yerbury Protein homeostasis, protein aggregation and amyotrophic laterial sclerosis APP1084144 $411,768
2011 Martina Sanderson-Smith Defining the role of plasminogen activation in group A streptococcal invasive APP1009369 $384,160
YearNameTitleAgency ref. no.Total
2017 Rodney Croft The Australian Centre for Electromagnetic Bioeffects Research APP1135076 $2,499,671
2012 Rodney Croft The Australian Centre for Electromagnetic Bioeffects Research APP1042464 $2,498,842
YearNameTitleAgency ref. no.Total
2016 Lyn Phillipson Consumer Directed Care: Understanding and promoting participation and care outcomes for people living with dementia in receipt of a Home Care Package APP1107401 $571,648
YearNameTitleTotal
2016 Dr Marco Petasecca, Prof Anatoly Rozenfeld, A/Prof Michael Lerch, Dr Joseph Bucci, Mr Marco Favoino, Mr Francesco Carriero 3D-BrachyView: a 3D real-time virtual reality intra-operative Quality Assurance system for brachytherapy $359,105
2015 Michael Lerch X-RATE: A novel radiation detector platform to realise new opportunities in radiotherapy at the Australian Synchrotron $337,077
2011 Michael Lerch Radiosurgery with sub-millimeter x-ray beams: development of the X-Tream realtime beam monitoring and Quality Assurance system $394,615
2010 Mark Walker Preclinical studies of group A streptococcal vaccine candidates $483,600
2010 Anatoly Rozenfeld BrachyVision: A novel multipurpose probe for in-body radiation imaging and dosimetry. $523,500
YearNameTitleTotal
2017 Jiamei Lian Early antipsychotic exposure during childhood and adolescence: Does it lead to long term brain and behaviour changes in adulthood? $318,768
2013 Deborah Apthorp Effects of electromagnetic radiation on visual processing $299,564
2011 Karen Mickle Understanding toe muscle weakness to restore foot function in older individuals with toe deformities $280,032
2011 Amy Wyatt The role of clusterin in preventing atherosclerosis $280,032
2010 Mei Han Understanding the role of neuregulin1 genetic polymorphisms in patients with schizophrenia $318,600
2010 Mark Davies Defining the emergence, initiation and evolution of invasive Streptococcal infections $309,668
2009  Yasmine Probst Supporting research underpinning evidence based practice: dietary assessment in clinical trials  $199,500 
2009 Debbie Watson Targeting the human immune response to bacterial superantigens $142,500
2009 Yinghua Yu Evaluation of functional protein molecules in treating obesity $341,768
YearNameAwardTitleTotal
2020 Yee Lian Chew Investigator Grant Emerging Leadership Level 1 Investigating Neuroendocrine Dysregulation as New Targets for Chronic Pain Management $639,750
2020 Monique Francois Investigator Grant Emerging Leadership Level 1 Optimising Lifestyle Treatment and Prevention of Diabetes $639,750
2020 Xu-Feng Huang Investigator Grant Leadership Level 2 Neurite deficits, obesity and cortical thinning: Prevention and treatment in schizophrenia $1,500,000
2020 Tony Okely Investigator Grant Leadership Level 2 Understanding and promoting physical activity and reducing sedentary behaviour in young children $2,000,000
YearNameTitleTotal
2018 Martina Sanderson-Smith Blood group antigen recognition by Group A Streptococcus mediates host colonisation $470,821
2017 Nadia Solowij Characterising neurobiological abnormalities in Cannabis Use Disorders $731,571.20
2017 Stephen Pyne, Paul Keller From lead compounds to potential therapeutics: Drugs to treat Clostridium Difficile Infections. $523,460.00
2017 Anatoly Rozenfeld, Michael Lerch, Marco Petasecca Fast and efficient assessment of dose in small targets in radiotherapy: Effect of motion in clinical research and implementation of dynamic therapy. $501,264.50
2016 Michael Kelso, Marie Ranson, Mingdong Huang Repurposing Amiloride into Breast Cancer Drugs with a Dual-Targeting Mechanism $611,966
2016 Chao Deng, Jiamei Lian Understanding the mechanisms for ameliorating/preventing antipsychoticinduced obesity in paediatric patients $576,495.50
2016 Amy Wyatt (New Investigator) The effect of hypochlorite on the toxicity and clearance of the Alzheimer's disease-associated amyloid beta peptide $461,495.50
2015  Moeava Tehei  Design and application of new nanomaterials theranostic platforms for targeted treatment of cancer  $514,154 
2015 Brett Garner Isoform-dependent apoE processing by human induced pluripotent stem cells. A novel pathway linking APOE genotype and Alzheimer’s disease risk. $416,660
2014 Anthony Okely Increasing physical activity among young children from disadvantaged communities: A group randomised controlled effectiveness trial $1,064,324
2014 Robert Kapsa Biopolymer Conduit for Peripheral Nerve Repair. $605,558
2014 Xu-Feng Huang Application of intelligent conducting polymers for treating schizophrenia and allied disorders focusing on neuronal outgrowth, myelination and synaptogenesis $675,558
2014 Lezanne Ooi Supporting a friend: the role of the molecular scaffold CoREST family in chromatin regulation and neuroprotection $343,447
2014 Brett Garner A novel roadblock to vitamin B12 transport in the brain $536,124
2013 Stephen Pyne The development of novel antibacterials targeting clostridium difficile infections $723,714
2013 Chao Deng Roles of muscarinic M3 receptors in antipsychoticinduced metabolic side-effects: prevention and treatment of anti-psychotic insulin dysregulation $583,611
2012 Nicholas Dixon Targeting Nucleic Acid Synthesis and Cell Division in Gram-Negative Bacterial Pathogens $934,319
2012 Xu-Feng Huang Schizophrenia: reversal of antipsychotic drug-induced obesity and its related metabolic disorders $597,987
2012 Anatoly Rozenfeld Improving radiation therapy of static and moving targets using high spatial resolution realtime dosimeters $526,325
2011 Nicholas Dixon Targeting lagging  strand DNA  replication in model  and pathogenic  bacteria $570,048
2011 Chao Deng Understanding the  mechanisms of  functionally selective  drugs: implication for  new generation  antipsychotic drugs $359,182
2011 Brett Garner Defining the function  of apolipoprotein­D in  Alzheimers disease $440,312
2011 Nadia Solowij Vulberability markers  in the association  between cannabis and  schizophrenia $499,006.40
2011 Justin Yerbury Investigating the  propagation of protein  aggregation in  amyotrophic lateral  sclerosis $390,812.40
YearNameTitleTotal
2010 Brett Garner Research Fellowships $234,329
YearNameTitleTotal
2016 Brett Garner Defining the mechanisms by which ABCA7 and apoE control Alzheimer's disease risk. Functional characterisation of new therapeutic targets for dementia prevention and treatment. $687,975
YearNameTitleTotal
2018 Kelly Lambert Implementing a health literacy focused dietetic outpatient model of care for people with chronic kidney disease $179,118
2014 Yasmine Probst From nutrients to foods to cuisines: Growing food composition data knowledge for more robust evidence-based advice $170,689

NHMRC grant enquiries

RAO University of Wollongong

Email: rao-uow@uow.edu.au 

Close